Jane Street’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Jane Street’s Portfolio DCPH Stock Details DCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-14,100	Closed	-$138K	–	11223
2021 Q4	$138K	Buy	+14,100	New	+$265K	﹤0.01%	9058
2020 Q3	–	Sell	-10,500	Closed	-$627K	–	8121
2020 Q2	$627K	Buy	+10,500	New	+$562K	﹤0.01%	4730

Other funds holding DCPH

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Jane Street's DCPH Position: Q2 2024 in Review

Jane Street sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2024, closing a stake of 14,779 shares — an estimated $232K sold.

Jane Street first reported a position in DCPH in Q2 2018 and held it in 17 quarters. The position peaked at $1.48M in Q4 2023. 1 fund tracked by Wall St. Rank holds DCPH as of Q2 2024.

Jane Street reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Jane Street sold 14,779 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $232K.
Jane Street first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q2 2018 and held it in 17 quarters.
Jane Street's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $1.48M in Q4 2023.
1 fund tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on Jane Street's 13F filing for Q2 2024, filed 15 Aug 2024.